A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy Participants
Clinical trial NCT04543383 · COMPLETED
Trial details
- NCT number
- NCT04543383
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2023-06-07
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.